← Back to Search

Brain Network Dynamics Study for Smoking Relapse Prevention

N/A
Recruiting
Research Sponsored by Penn State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 2 (visit 2)
Awards & highlights

Study Summary

This trial will use brain scans (fMRI) to understand why smokers lapse, helping create better strategies to quit. #quitnow

Who is the study for?
This trial is for smokers aged 21-65 who have smoked at least six cigarettes daily over the past year and can speak English fluently. They must pass an MRI safety screening and show a carbon monoxide level above 10 ppm to confirm smoking status. Those unwilling to abstain from nicotine for 12 hours before lab visits or with risks related to MRIs, like pacemakers or metallic objects in their body, cannot join.Check my eligibility
What is being tested?
The study uses fMRI scans while participants perform tasks that simulate situations leading to a smoking lapse. It aims to identify brain activity patterns linked to the urge of smoking and understand mental processes preceding a lapse, which could help prevent relapses.See study design
What are the potential side effects?
There are no direct side effects mentioned for this trial as it involves non-invasive fMRI scanning and laboratory tasks without medication intervention. However, discomfort from abstaining from nicotine or staying still during MRI may occur.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 2 (visit 2)
This trial's timeline: 3 weeks for screening, Varies for treatment, and day 2 (visit 2) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Blood-oxygen-level dependent (BOLD) signal
Self-reported affect
Secondary outcome measures
Self-reported craving and nicotine withdrawal symptoms

Trial Design

1Treatment groups
Experimental Treatment
Group I: fMRI smoking lapse taskExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

Penn State UniversityLead Sponsor
355 Previous Clinical Trials
125,607 Total Patients Enrolled
2 Trials studying Smoking
578 Patients Enrolled for Smoking

Media Library

Laboratory task modeling smoking lapse behavior Clinical Trial Eligibility Overview. Trial Name: NCT05572671 — N/A
Smoking Research Study Groups: fMRI smoking lapse task
Smoking Clinical Trial 2023: Laboratory task modeling smoking lapse behavior Highlights & Side Effects. Trial Name: NCT05572671 — N/A
Laboratory task modeling smoking lapse behavior 2023 Treatment Timeline for Medical Study. Trial Name: NCT05572671 — N/A
Smoking Patient Testimony for trial: Trial Name: NCT05572671 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Could you confirm if this clinical trial is still accepting participants?

"According to clinicaltrials.gov, this specific research project is not currently seeking candidates despite having been initially posted on December 1st 2022 and most recently updated on October 5th 2022. However, a total of 110 other trials are actively recruiting at the present time."

Answered by AI

Does this investigation encompass geriatric participants?

"According to the given criteria, only individuals between ages 21 and 55 may qualify for this trial. There are 16 studies available for minors while 82 trials accept patients above 65 years old."

Answered by AI

What criteria must individuals meet to be eligible for participation in this medical experiment?

"To be eligible for the trial, applicants must possess a history of tobacco use and fall within the age range of 21 to 55. The total number of participants needed is around 150 individuals."

Answered by AI

Who else is applying?

What state do they live in?
Texas
What portion of applicants met pre-screening criteria?
Met criteria
Did not meet criteria
How many prior treatments have patients received?
0
1
What site did they apply to?
The Pennsylvania State University

Why did patients apply to this trial?

Soy funadora activa desde hace Mas de 20 anos.
PatientReceived 2+ prior treatments
Recent research and studies
clinicaltrials.govStudy
Linking Brain Network Dynamics to Imminent Smoking Lapse Risk and Behavior
Stephen Wilson 2023. "Linking Brain Network Dynamics to Imminent Smoking Lapse Risk and Behavior". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05572671.
~100 spots leftby Mar 2027
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top